Amy Mahery
Vermogen: 5 $ op 30-06-2026
Vermogen: 5 $ op 30-06-2026
Ms. Amy Mahery is an Independent Director at CNS Pharmaceuticals, Inc. She is on the Board of Directors at CNS Pharmaceuticals, Inc. Ms. Mahery was previously employed as a Chief Commercial Officer by Roivant Sciences Ltd. and a Senior Vice President by EMD Serono, Inc. She received her undergraduate degree from Trinity College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 1 ( 0% ) | 5 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 18-01-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01-12-2024 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01-07-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau